Effect of Stretching on Visco-elastic Behaviour of the Fascia Plantaris in a Healthy Population
Sponsor
University Ghent (Other)
Overall Status
Completed
CT.gov ID
NCT05153993
Collaborator
(none)
60
1
2
7.1
8.5
Study Details
Study Description
Brief Summary
RCT with two arms: (1) stretch fascia plantaris (6 weeks, n=30) (2) control (n=30); Outcome parameters: ROM ankle and first toe; visco-elastic behaviour of the fascia plantaris determined by means of myotonometry Study protocol: Outcome parameters were evaluated before and after the intervention/control with a 6 weeks interval. All participants were screened bilaterally and for the participants assigned to the intervention group stretching was only performed on the dominant side
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Study Design
Study Type:
Interventional
Actual Enrollment
:
60 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Investigator, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Effect of Stretching on Visco-elastic Behaviour of the Fascia Plantaris in a Healthy Population
Actual Study Start Date
:
Oct 1, 2017
Actual Primary Completion Date
:
Dec 20, 2017
Actual Study Completion Date
:
May 5, 2018
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: Stretch fascia plantaris
|
Other: Fascia stretch
Stretch of the fascia plantaris during 3x30", 5x/week, 6 weeks
|
No Intervention: Control group
|
Outcome Measures
Primary Outcome Measures
- Visco-elastic behaviour using myotonometry [within 20 minutes before and after intervention]
By means of the MyotonPro device
Secondary Outcome Measures
- Range of Motion of ankle joint and first metatarsalphalangeal joint [within 20 minutes before and after intervention]
By means of goniometry
Eligibility Criteria
Criteria
Ages Eligible for Study:
N/A
and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
- Healthy volunteers
Exclusion Criteria:
- Lower extremity injury
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Roel De Ridder | Ghent | East Flanders | Belgium | 9000 |
Sponsors and Collaborators
- University Ghent
Investigators
- Principal Investigator: Roel De Ridder, University Ghent
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
University Ghent
ClinicalTrials.gov Identifier:
NCT05153993
Other Study ID Numbers:
- 2017/1215
First Posted:
Dec 10, 2021
Last Update Posted:
Dec 10, 2021
Last Verified:
Nov 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms: